Published in Women's Health Weekly, May 29th, 2006
According to a report from London, "The greatest potential for the chemoprevention of cervical cancer is in women with human papillomavirus (HPV) infection, an abnormal screening test or a non-invasive neoplastic lesion. Potential chemopreventive agents include micronutrients, antiviral agents and immune modifiers."
P. Sasieni of Queen Mary University wrote, "Randomized controlled clinical trials have generally been small and the results have not been encouraging. Beneficial effects on neoplasia have been shown for a couple of agents that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.